Search Results - "Peloso, P.M"

A discrete-choice experiment of United Kingdom patients' willingness to risk adverse events for improved function and pain control in osteoarthritis by Hauber, A.B, Arden, N.K, Mohamed, A.F, Johnson, F.R, Peloso, P.M, Watson, D.J, Mavros, P, Gammaitoni, A, Sen, S.S, Taylor, S.D

“…Summary Objective To assess patient preferences for treatment-related benefits and risks associated with the use of nonsteroidal anti-inflammatory drugs…”
Get full text

Longitudinal assessment of pain in patients with knee osteoarthritis (OA): using data from the Study of Real World Therapies (SORT) by Rannou, F, Peloso, P.M, Rajagopalan, S, Mavros, P, Everett, S.V, Arden, N, Conaghan, P, Phillips, C.J, Moore, R.A, van de Laar, M, Taylor, S.D

Get full text

Inadequate Pain Relief Among Patients With Primary Knee Osteoarthritis - Analysis From The Portuguese Sample Of The Survey Of Osteoarthritis Real World Therapies (Sort) by Laires, P, Laíns, J, Miranda, L, Cernadas, R, Pereira, da Silva J, Gomes, J.M, Peloso, P.M, Taylor, S.D, Silva, J.C

Get full text

Inadequate pain relief (IPR) in knee osteoarthritis: what does it look like? a European survey of osteoarthritis real world therapies (SORT) by Conaghan, P, Rannou, F, Arden, N, Everett, S.V, Balshaw, R, Peloso, P.M, Watson, D.J, Sen, S.S, Taylor, S.D

Get full text

A European Assessment Of The Impact Of Inadequate Pain Relief (Ipr) On Health-Related Quality Of Life (Qol) In Patients With Knee Osteoarthritis (Oa) In The Survey Of Real World Therapies (Sort) by Black, C.M, Stokes, L, Phillips, C, Peloso, P.M, Mavros, P, Everett, S.V, Moore, A, Conaghan, P, Sen, S, Taylor, S.D

Get full text

Safety issues in the development of treatments for osteoarthritis: recommendations of the Safety Considerations Working Group by Strand, V, Bloch, D.A, Leff, R, Peloso, P.M, Simon, L.S

“…Summary Objective The symptomatic treatment of osteoarthritis (OA) remains to be improved, as many patients do not respond well to current palliative therapies…”
Get full text

Short Run Dynamics of Inadequate Pain Relief (IPR): Evidence from a European Multinational Survey of Real World Therapies (SORT) by Mavros, P, Black, C.M, Peloso, P.M, Stokes, L, Philips, C, Moore, A, Conaghan, P, Rannou, F, Arden, N, van de Laar, M, Taylor, S.D

Get full text

Elagolix reduced dyspareunia and improved health-related quality of life in premenopausal women with endometriosis-associated pain by Leyland, N., Taylor, H.S., Archer, D.F., Peloso, P.M., Schwefel, B., Soliman, A.M., Martinez, M., Abrao, M.S.

Get full text

Maintenance of endometriosis-associated pain reduction and quality of life improvement in phase 3 extension studies with elagolix by Taylor, H.S., Johnson, N., Carr, B., Leyland, N., Rechberger, T., Duan, W.R., Peloso, P.M., Soliman, A.M., Schwefel, B., Chwalisz, K.

Get full text

Long-term effect of elagolix on bone mineral density: results from two phase 3 extension studies in women with endometriosis-associated pain by Archer, D.F., Watts, N., Gallagher, C., Surrey, E., Leyland, N., Duan, W.R., Schwefel, B., Peloso, P.M., Chwalisz, K.

Get full text

Long-term safety and efficacy of elagolix treatment in women with endometriosis-associated pain: primary results from two phase 3 extension studies by Surrey, E., Taylor, H.S., Giudice, L.C., Singh, S., Abrao, M.S., Lessey, B.A., Duan, W.R., Peloso, P.M., Schwefel, B., Chwalisz, K.

Get full text

61 - Long-Term Safety and Efficacy of Elagolix Treatment in Women with Endometriosis-Associated Pain: Primary Results From Two Phase 3 Extension Studies by Surrey, E., Taylor, H.S., Giudice, L.C., Singh, S.S., Abrao, M.S., Lessey, B.A., Duan, W.R., Peloso, P.M., Schwefel, B., Chwalisz, K.

Get full text

Long-Term Safety and Efficacy of Elagolix Treatment in Women with Endometriosis-Associated Pain: Primary Results From Two Phase 3 Extension Studies by Surrey, E., Taylor, H.S., Giudice, L.C., Singh, S.S., Abrao, M.S., Lessey, B.A., Duan, W.R., Peloso, P.M., Schwefel, B., Chwalisz, K.

Get full text

PMS74 - Inadequate Pain Relief Among Patients With Primary Knee Osteoarthritis - Analysis From The Portuguese Sample Of The Survey Of Osteoarthritis Real World Therapies (Sort) by Laires, P., Laíns, J., Miranda, L., Cernadas, R., Pereira, da Silva J., Gomes, J.M., Peloso, P.M., Taylor, S.D., Silva, J.C.

Get full text

PMS55 - A European Assessment Of The Impact Of Inadequate Pain Relief (Ipr) On Health-Related Quality Of Life (Qol) In Patients With Knee Osteoarthritis (Oa) In The Survey Of Real World Therapies (Sort) by Black, C.M., Stokes, L., Phillips, C., Peloso, P.M., Mavros, P., Everett, S.V., Moore, A., Conaghan, P., Sen, S., Taylor, S.D.

Get full text

PMS83 - Short Run Dynamics of Inadequate Pain Relief (IPR): Evidence from a European Multinational Survey of Real World Therapies (SORT) by Mavros, P., Black, C.M., Peloso, P.M., Stokes, L., Philips, C., Moore, A., Conaghan, P., Rannou, F., Arden, N., van de Laar, M., Taylor, S.D.

Get full text

Specialty Update by Graham, N, Gross, A, Goldsmith, C.H, Klaber Moffett, J, Haines, T, Burnie, S.J, Peloso, P.M

Get full text

Further assessment of the clinically effective dose range of etoricoxib: a randomized, double-blinded, placebo-controlled trial in rheumatoid arthritis by Greenwald, M., Peloso, P.M., Mandel, D., Soto, O., Mehta, A., Frontera, N., Boice, J.A., Zhan, X.J., Curtis, S.P.

“…Abstract Objective: To further assess the clinically active dose range of etoricoxib, a COX-2 selective inhibitor, in rheumatoid arthritis (RA). Methods: RA…”
Get full text

Effects of hylan on amphotericin-induced carpal lameness in equids by Peloso, J G, Stick, J A, Caron, J P, Peloso, P M, Soutas-Little, R W

“…In this double-blind study, the effectiveness of and dose response to intra-articular administration of modified hyaluronan (hylan) was determined in an equine…”
Get more information